Chronic Urticaria
Showing 1 - 25 of >10,000
Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab
Not yet recruiting
- Chronic Spontaneous Urticaria
- Chronic Urticaria, Idiopathic
- omalizumab 300 mg every four weeks
- omalizumab 300 mg every six weeks
-
Copenhagen, Copenhagen N, DenmarkDepartment of Dermatology, Bispebjerg Hospital
Jun 21, 2023
Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous
Not yet recruiting
- Chronic Spontaneous Urticaria
- Adenosine deaminase serum level
- IgE antibodies serum level
- (no location specified)
Aug 7, 2023
Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)
Suspended
- Chronic Spontaneous Urticaria
- ABT Online Programme
- Delayed Control group
-
Dublin, IrelandSt James's Hospital
Oct 25, 2023
Xolair® in Pediatric Chronic Spontaneous Urticaria in China
Not yet recruiting
- Chronic Spontaneous Urticaria
- Xolair
- (no location specified)
Sep 19, 2023
Urticaria Trial in Taichung (Vitamin D, Placebo)
Recruiting
- Urticaria
- Vitamin D
- Placebo
-
Taichung, TaiwanChina Medical University Hospital
Aug 12, 2022
Chronic Spontaneous Urticaria Trial in Jacksonville (Nucala)
Recruiting
- Chronic Spontaneous Urticaria
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 30, 2022
Healthy Participants, Chronic Spontaneous Urticaria Trial in Anniston (AK006, Placebo)
Recruiting
- Healthy Participants
- Chronic Spontaneous Urticaria
- AK006
- Placebo
-
Anniston, AlabamaSite 601-001 Healthy Volunteer Clinical Research Unit
Oct 2, 2023
Chronic Urticaria, Anxiety Trial in Kayseri (Positive Psychotherapy Based Counseling)
Not yet recruiting
- Chronic Urticaria
- Anxiety
- Positive Psychotherapy Based Counseling
-
Kayseri, TurkeyErciyes Universty
Aug 22, 2022
Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
Recruiting
- Spontaneous Urticaria, Chronic
-
Lille, FranceHop Claude Huriez Chu Lille
Jan 25, 2023
Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)
Not yet recruiting
- Chronic Idiopathic Urticaria
- Omalizumab Injection
- Xolair Prefilled Syringe
- (no location specified)
Mar 7, 2023
Food-specific IgG4-guided Elimination Diets Improve Allergy
Completed
- Rhinitis, Allergic
- +4 more
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital,School of Medicine,Zhejiang Universit
Sep 25, 2023
Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)
Not yet recruiting
- Chronic Spontaneous Urticaria
- Remibrutinib
- +3 more
- (no location specified)
Sep 20, 2023
Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)
Recruiting
- Chronic Spontaneous Urticaria
- Oral EP262
- Placebo
-
Birmingham, Alabama
- +7 more
Oct 5, 2023
Chronic Urticaria, Idiopathic Trial in Aurora (Omalizumab)
Recruiting
- Chronic Urticaria, Idiopathic
-
Aurora, ColoradoUniversity of Colorado Anschutz
Mar 23, 2022
Chronic Spontaneous Urticaria Trial (Cohort 1: TLL018 tablets, Cohort 2: TLL018 tablets, Cohort 3: TLL018 tablets)
Not yet recruiting
- Chronic Spontaneous Urticaria
- Cohort 1: TLL018 tablets
- +2 more
- (no location specified)
May 10, 2022
Chronic Spontaneous Urticaria (CSU) Trial (LOU064 (blinded), Placebo, LOU064 (open label))
Not yet recruiting
- Chronic Spontaneous Urticaria (CSU)
- LOU064 (blinded)
- +2 more
- (no location specified)
Aug 22, 2022
Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,
Recruiting
- Allergic Disease
- +3 more
- YH35324
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +4 more
Jul 24, 2023
Detection of Viral Particels in Urticaria Patients
Recruiting
- Urticaria Chronic
-
Afula, IsraelEmek Medical Center
Mar 15, 2022
Chronic Urticaria Trial in Shatin (Modified Xiao-Feng Powder + Antiallergics, Placebo + Antiallergics)
Recruiting
- Chronic Urticaria
- Modified Xiao-Feng Powder + Antiallergics
- Placebo + Antiallergics
-
Shatin, Hong KongThe Chinese University of Hong Kong
Dec 1, 2021
Chronic Spontaneous Urticaria Trial in Japan (TAS5315 Dose 1, TAS5315 Dose 2, TAS5315 Dose 3)
Recruiting
- Chronic Spontaneous Urticaria
- TAS5315 Dose 1
- +5 more
-
Fukuoka, Japan
- +4 more
Aug 15, 2022
Healthy Study Participants, Chronic Spontaneous Urticaria Trial in Sofia (UCB8600, Placebo)
Terminated
- Healthy Study Participants
- Chronic Spontaneous Urticaria
- UCB8600
- Placebo
-
Sofia, BulgariaUp0086 001
Jul 15, 2022
Chronic Spontaneous Urticaria Trial (LOU064 (blinded), )
Not yet recruiting
- Chronic Spontaneous Urticaria
- LOU064 (blinded)
- placebo
- (no location specified)
Dec 23, 2022